US regulatory status: approved.
pharma · Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy (DMD) · TRDA
Entrada Therapeutics
Entrada Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Boston, USA HQ
2016 Founded
201 Employees
Public company Type
TRDA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2016
- Employees
- 201
- Programs
- 4
- Drugs
- 4
- Patents
- 5
Entrada Therapeutics pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Entrada Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Entrada Therapeutics in public FDA and regional records.
-
US regulatory status: approved.
-
Development asset linked to Entrada Therapeutics in public FDA and regional records.